Phase Ib trial of bryostatin 1 in patients with refractory malignancies
GRANT, S, ROBERTS, J, POPLIN, E, TOMBES, M. B, KYLE, B, WELCH, D, CARR, M, BEAR, H. D
Published in Clinical cancer research (01.03.1998)
Get full text
Published in Clinical cancer research (01.03.1998)
Journal Article
Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation
ROBERTS, J. D, POPLIN, E. A, TOMBES, M. B, KYLE, B, SPICER, D. V, GRANT, S, SYNOLD, T, MORAN, R
Published in Cancer chemotherapy and pharmacology (12.01.2000)
Published in Cancer chemotherapy and pharmacology (12.01.2000)
Get full text
Journal Article
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks
ROBERTS, J. D, SHIBATA, S, PARADISO, L. J, CLENDENINN, N. J, SPICER, D. V, MCLEOD, H. L, TOMBES, M. B, KYLE, B, CARROLL, M, SHEEDY, B, COLLIER, M. A, PITHAVALA, Y. K
Published in Cancer chemotherapy and pharmacology (2000)
Published in Cancer chemotherapy and pharmacology (2000)
Get full text
Journal Article
Re Two Sectors of Beirut Are Worlds Apart (June 23): The National Council of Churches, in a report on Lebanon issued May 5, 1981, noted that it is inaccurate to label as "Christian" the "armed militias of several predominantly Maronite Christian political parties," as this suggests the parties officially represent the Maronite Church or all Christians and ignores the fact that other Christians - Eastern Orthodox, for example - are among major supporters and leaders in some of the groups labeled
Get full text
Newspaper Article